Keith McCrae, MD of Cleveland Clinic gives his view on pomalidomide in HHT care at the 58th ASH Annual Meeting in San Diego, CA.
Pomalidomide Could Become Leading Drug in HHT Care
Keith McCrae, MD of Cleveland Clinic gives his view on pomalidomide in HHT care at the 58th ASH Annual Meeting in San Diego, CA.